10 things innovators should know about novel cancer targets at AACR19
Pierre de Coubertin Statue, Atlanta
On BSB we write about the science driving innovation in the biotechnology and pharmaceutical industry, and how that translates into new product development.
One of our favorite meetings of the cancer conference calendar is the annual meeting of the American Association for Cancer Research (AACR). The 2019 annual meeting starts in Atlanta later this week and is the cancer research mecca that we and others will be heading to later this week.
Ahead of the meeting we’re continuing our #AACR19 previews with a look at some of the innovative, novel cancer agents we expect to hear more about in Atlanta.
To learn more from our latest conference coverage and oncology insights, subscribers can log-in or you can click to gain access to BSB Premium Content.
This content is restricted to subscribers
